Your browser doesn't support javascript.
loading
A Case of ALG6-CDG with Explosive Onset of Intractable Epilepsy During Infancy.
Clark, Daniel James; Murray, Thomas; Drees, Michael; Kulkarni, Neil.
Afiliação
  • Clark DJ; Division of Neurology, Nationwide Children's Hospital, Columbus, OH, USA.
  • Murray T; Division of Neurology, Nationwide Children's Hospital, Columbus, OH, USA.
  • Drees M; Rush Medical College, Chicago, IL, USA.
  • Kulkarni N; Division of Neurology, Nationwide Children's Hospital, Columbus, OH, USA.
Child Neurol Open ; 10: 2329048X231153781, 2023.
Article em En | MEDLINE | ID: mdl-36756224
ABSTRACT
ALG6-CDG is a rare, but second most common, type 1 congenital disorder of glycosylation (CDG) caused by a defect in the α-1-3-glucosyltransferase (ALG6) enzyme in the N-glycan assembly pathway. Many mutations have been identified and inherited in an autosomal recessive pattern. There are less than 100 ALG6-CDG cases reported, all sharing the phenotype of hypotonia and developmental delay. The majority (perhaps >70%) have seizures, but a minority have intractable epilepsy or epileptic encephalopathy. We report the clinical course, EEG findings, and neuroimaging of a child found to have compound heterozygous alleles c.257 + 5G > A and c.680G > A (p.G227E) who developed explosive onset of intractable epilepsy and epileptic encephalopathy. Initially, CDG was not suspected due to its rarity and lack of multi-organ system involvement, but rapid whole exam sequence (8-day turnaround) revealed the specific diagnosis quickly.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article